Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Current assets:
Cash	$ 451	$ 55
Accounts receivable, net	2,179	2,419
Inventories	5,698	6,431
Investment in iBio, Inc.	532	684
Other current assets	306	339
Total current assets	9,166	9,928
Intangible assets, net	880	1,017
Property and equipment, net	1,239	1,235
Security deposits and other assets	298	431
Total assets	11,583	12,611
Current liabilities:
Advances under revolving credit facility	4,121	4,543
Accounts payable (includes $184 and $186 due to a related party for 2014 and 2013)	5,635	5,883
Accrued expenses and other current liabilities	1,309	1,122
Current portion of long term debt	588	868
Total current liabilities	11,653	12,416
Long term debt	4,359	4,888
Subordinated convertible note, net - CD Financial, LLC	5,009	4,901
Derivative liabilities	717	696
Total liabilities	21,738	22,901
Commitments and contingencies
Stockholders' deficiency:
Common Stock, par value $0.002 per share; shares authorized 50,000,000; shares issued were 21,140,074 and 21,115,074, respectivley and shares outstanding were 21,105,174 and 21,080,174, respectivley	42	42
Additional paid-in-capital	44,572	44,568
Accumulated deficit	(54,670)	(54,801)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total stockholders' deficiency	(10,155)	(10,290)
Total liabilities and stockholders' deficiency	$ 11,583	$ 12,611